• Something wrong with this record ?

IL-6 and its role in IgA nephropathy development

Y. Groza, J. Jemelkova, LR. Kafkova, P. Maly, M. Raska

. 2022 ; 66 (-) : 1-14. [pub] 20220420

Language English Country Great Britain

Document type Journal Article, Review

IL-6 is considered one of the well characterized cytokines exhibiting homeostatic, pro- and anti-inflammatory activities, depending on the receptor variant and the induced intracellular cis- or trans-signaling responses. IL-6-activated pathways are involved in the regulation of cell proliferation, survival, differentiation, and cell metabolism changes. Deviations in IL-6 levels or abnormal response to IL-6 signaling are associated with several autoimmune diseases including IgA nephropathy (IgAN), one of most frequent primary glomerulonephritis worldwide. IgAN is associated with increased plasma concentration of IL-6 and increased plasma concentration of aberrantly galactosylated IgA1 immunoglobulin (Gd-IgA1). Gd-IgA1 is specifically recognized by autoantibodies, leading to the formation of circulating immune complexes (CIC) with nephritogenic potential, since CIC deposited in the glomerular mesangium induce mesangial cells proliferation and glomerular injury. Infection of the upper respiratory or digestive tract enhances IL-6 production and in IgAN patients is often followed by the macroscopic hematuria. This review recapitulates general aspects of IL-6 signaling and summarizes experimental evidences about IL-6 involvement in the etiopathogenesis of IgA nephropathy through the production of Gd-IgA1 and regulation of mesangial cell proliferation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017800
003      
CZ-PrNML
005      
20220804134410.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cytogfr.2022.04.001 $2 doi
035    __
$a (PubMed)35527168
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Groza, Yaroslava $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec 252 50, Czech Republic
245    10
$a IL-6 and its role in IgA nephropathy development / $c Y. Groza, J. Jemelkova, LR. Kafkova, P. Maly, M. Raska
520    9_
$a IL-6 is considered one of the well characterized cytokines exhibiting homeostatic, pro- and anti-inflammatory activities, depending on the receptor variant and the induced intracellular cis- or trans-signaling responses. IL-6-activated pathways are involved in the regulation of cell proliferation, survival, differentiation, and cell metabolism changes. Deviations in IL-6 levels or abnormal response to IL-6 signaling are associated with several autoimmune diseases including IgA nephropathy (IgAN), one of most frequent primary glomerulonephritis worldwide. IgAN is associated with increased plasma concentration of IL-6 and increased plasma concentration of aberrantly galactosylated IgA1 immunoglobulin (Gd-IgA1). Gd-IgA1 is specifically recognized by autoantibodies, leading to the formation of circulating immune complexes (CIC) with nephritogenic potential, since CIC deposited in the glomerular mesangium induce mesangial cells proliferation and glomerular injury. Infection of the upper respiratory or digestive tract enhances IL-6 production and in IgAN patients is often followed by the macroscopic hematuria. This review recapitulates general aspects of IL-6 signaling and summarizes experimental evidences about IL-6 involvement in the etiopathogenesis of IgA nephropathy through the production of Gd-IgA1 and regulation of mesangial cell proliferation.
650    _2
$a galaktosa $x metabolismus $7 D005690
650    _2
$a glomerulární mesangium $x metabolismus $7 D005920
650    12
$a IgA nefropatie $x metabolismus $x patologie $7 D005922
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin A $x metabolismus $7 D007070
650    _2
$a interleukin-6 $x metabolismus $7 D015850
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Jemelkova, Jana $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc 779 00, Czech Republic
700    1_
$a Kafkova, Leona Raskova $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc 779 00, Czech Republic. Electronic address: leona.raskova@upol.cz
700    1_
$a Maly, Petr $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec 252 50, Czech Republic
700    1_
$a Raska, Milan $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc 779 00, Czech Republic. Electronic address: milan.raska@upol.cz
773    0_
$w MED00008700 $t Cytokine & growth factor reviews $x 1879-0305 $g Roč. 66, č. - (2022), s. 1-14
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35527168 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134404 $b ABA008
999    __
$a ok $b bmc $g 1821751 $s 1169043
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 66 $c - $d 1-14 $e 20220420 $i 1879-0305 $m Cytokine & growth factor reviews $n Cytokine Growth Factor Rev $x MED00008700
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...